Gilberto Payares Selected Research

3- ((2- benzyl- 6- (3- methoxypropyloxy)pyridin- 3- yl)ethynyl)quinuclidin- 3- ol

7/2004

In vitro and in vivo activities of E5700 and ER-119884, two novel orally active squalene synthase inhibitors, against Trypanosoma cruzi.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gilberto Payares Research Topics

Disease

3	Chagas Disease (American Trypanosomiasis) 02/2006 - 01/2003
2	Cutaneous Leishmaniasis 12/2009 - 12/2006
1	Infections 02/2010
1	Leishmaniasis 12/2009
1	Mucocutaneous Leishmaniasis 12/2009
1	Body Weight (Weight, Body) 07/2004
1	Parasitemia 07/2004

Drug/Important Bio-Agent (IBA)

2	Amiodarone (Amiodarona)FDA LinkGeneric 12/2009 - 02/2006
1	Merozoite Surface Protein 1 (MSA1)IBA 02/2010
1	Monoclonal AntibodiesIBA 02/2010
1	AntibodiesIBA 02/2010
1	Pharmaceutical PreparationsIBA 12/2009
1	Drug CombinationsIBA 12/2009
1	miltefosine (Impavido)IBA 12/2009
1	Adenosine Triphosphate (ATP)IBA 12/2006
1	Glyburide (Glibenclamide)FDA LinkGeneric 12/2006
1	3- ((2- benzyl- 6- (3- methoxypropyloxy)pyridin- 3- yl)ethynyl)quinuclidin- 3- olIBA 07/2004
1	TAK 187IBA 01/2003
1	TriazolesIBA 01/2003
1	ER 30346 (ravuconazole)IBA 01/2003

Therapy/Procedure

1	Therapeutics 02/2006